黄芪雷公藤合剂对链脲菌素诱导的糖尿病大鼠肾损伤的防治效果  被引量:2

Prevention and Treatment of Radix Astragalus and Tripterygiumforrestii Compound on Nephropathy Damages in Diabetic Rats

在线阅读下载全文

作  者:涂晓[1] 程晓霞[1] 陈洪宇[1] 姜聪娇[1] 

机构地区:[1]浙江中医药大学附属广兴医院(杭州市中医院),杭州310007

出  处:《浙江中医药大学学报》2009年第2期164-165,共2页Journal of Zhejiang Chinese Medical University

基  金:杭州市科技局立项课题(No:20070433Q09)~~

摘  要:[目的]研究黄芪雷公藤合剂对糖尿病(DM)大鼠肾损伤的治疗作用。[方法]DM模型大鼠分为正常对照组,空白对照组,科素亚治疗组,雷公藤水煎剂治疗组,黄芪雷公藤合剂低、中、高剂量组,除正常对照组外其余各组依次分别给予自来水,科素亚,雷公藤水煎剂,低、中、高剂量黄芪雷公藤合剂,对比观察尿蛋白排泄,血肌酐,血总胆固醇。[结果]黄芪雷公藤合剂能降低实验大鼠的尿蛋白和血肌酐,中大剂量的黄芪雷公藤合剂的降尿蛋白及降血肌酐作用优于科素亚及雷公藤水煎剂,并在改善DN大鼠的脂代谢紊乱方面作用明显优于科素亚。[结论]黄芪雷公藤合剂对STZ诱导DM大鼠肾损伤具有防治作用。[Objective] To investigate the effects of the radix astragalus and tripterygiumforrestii compound on the nephropathy damages in diabetic rats. [Methods] All the rats were induced by injecting streptozotocin(STZ) into abdomen, and were divided into seven groups: normal control group, model group, western medicine group (treated with Lossartan Potassium Tablets), Chinese herbs control group(treated with tripterygiumforrestii), high dose treatment group (HDT group), medium dose treatment group (MDT group) ,low dose treatment group (LDT group). The urine protein, serum creatine and cholesterol were tested and compared among the groups.[Result] The radix astragalus and tripterygiumforrestii compound has the function of reducing the level of urine protein and serum creatine in rats. The functions of MDT group and HDT group are better than western medicine group and Chinese herbs control group in reducing urine protein and serum creatine and they play significantly better than losartan in regulating the lipid metabolic disorder in rats. [Conclusion]The radix astragalus and tripterygiumforrestii compound has positive effect in treating the nephropathy damages in diabetic rats induced by STZ.

关 键 词:黄芪雷公藤合剂 糖尿病 肾损伤 大鼠 

分 类 号:R285.5[医药卫生—中药学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象